Interestingly, further stratified analysis by baseline tumor cell PD-L1 status has shown that patients with PD-L1 expression on tumor cell of at least 1% have higher ORR compared with patients with PD-L1 expression on tumor cell of less than 1% (26% vs. 19%). The gene discussed is CD274; the disease is neoplasm.